<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00420810</url>
  </required_header>
  <id_info>
    <org_study_id>0928-049</org_study_id>
    <secondary_id>2006_514</secondary_id>
    <nct_id>NCT00420810</nct_id>
  </id_info>
  <brief_title>Adult Polysomnography Primary Insomnia Cross Over Study (0928-049)(TERMINATED)</brief_title>
  <official_title>A Double-Blind, Placebo Controlled, Randomized, Cross-Over Polysomnographic Study of MK0928 15 mg in Adult Patients With Primary Insomnia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>H. Lundbeck A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>H. Lundbeck A/S</source>
  <brief_summary>
    <textblock>
      The purpose of this study is determine whether this drug will improve your insomnia in terms&#xD;
      of decreasing your time to fall asleep and allowing you to stay asleep longer. The drug will&#xD;
      be compared against placebo in order to determine if there's a difference.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>September 2006</start_date>
  <primary_completion_date type="Actual">March 2007</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Wake after sleep onset and Latency to persistent sleep</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subjective total sleep time and subjective time to sleep onset</measure>
  </secondary_outcome>
  <enrollment>138</enrollment>
  <condition>Primary Insomnia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>MK0928 / Duration of Treatment : 8 Weeks</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of Primary Insomnia&#xD;
&#xD;
          -  Patient is willing to stay overnight at a sleep laboratory for a total of 7 nights&#xD;
&#xD;
          -  Patient is willing to avoid alcohol on PSG visits&#xD;
&#xD;
          -  Patient will avoid napping during the course of the study&#xD;
&#xD;
          -  Patient's bedtime is between 9pm and 1am&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of substance abuse, bipolar disorder or psychotic disorder&#xD;
&#xD;
          -  Difficulty sleeping due to other medical condition&#xD;
&#xD;
          -  History of narcolepsy, circadian rhythm sleep disorder, parasomnia, sleep apnea,&#xD;
             periodic limb movements or restless legs syndrome&#xD;
&#xD;
          -  History of neoplastic malignancy within the last 5 years&#xD;
&#xD;
          -  Positive alcohol breath test during the screening visits&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Monitor</last_name>
    <role>Study Director</role>
    <affiliation>Merck Sharp &amp; Dohme Corp.</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>January 2015</verification_date>
  <study_first_submitted>January 5, 2007</study_first_submitted>
  <study_first_submitted_qc>January 10, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 11, 2007</study_first_posted>
  <last_update_submitted>January 13, 2015</last_update_submitted>
  <last_update_submitted_qc>January 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 14, 2015</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

